123 related articles for article (PubMed ID: 19106583)
1. [Clinical trial of non-specific immunotherapy using Lentinan in advanced or recurrent gastric cancer].
Yoshino S; Oka M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2239-43. PubMed ID: 19106583
[TBL] [Abstract][Full Text] [Related]
2. [S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer].
Nimura H; Mitsumori N; Takahashi N; Kashimura H; Takayama S; Kashiwagi H; Yanaga K
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():106-9. PubMed ID: 16897983
[TBL] [Abstract][Full Text] [Related]
3. Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701).
Yoshino S; Nishikawa K; Morita S; Takahashi T; Sakata K; Nagao J; Nemoto H; Murakami N; Matsuda T; Hasegawa H; Shimizu R; Yoshikawa T; Osanai H; Imano M; Naitoh H; Tanaka A; Tajiri T; Gochi A; Suzuki M; Sakamoto J; Saji S; Oka M
Eur J Cancer; 2016 Sep; 65():164-71. PubMed ID: 27501505
[TBL] [Abstract][Full Text] [Related]
4. [The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].
Sugimoto N; Narahara H; Sakai D; Yamamoto S; Fumoto S; Yagi T; Imamura F; Iishi H; Tatsuta M
Gan To Kagaku Ryoho; 2009 Mar; 36(3):417-24. PubMed ID: 19295265
[TBL] [Abstract][Full Text] [Related]
5. Lentinan with S-1 and paclitaxel for gastric cancer chemotherapy improve patient quality of life.
Kataoka H; Shimura T; Mizoshita T; Kubota E; Mori Y; Mizushima T; Wada T; Ogasawara N; Tanida S; Sasaki M; Togawa S; Sano H; Hirata Y; Ikai M; Mochizuki H; Seno K; Itoh S; Kawai T; Joh T
Hepatogastroenterology; 2009; 56(90):547-50. PubMed ID: 19579640
[TBL] [Abstract][Full Text] [Related]
6. [Combination chemotherapy of S-1/low-dose CDDP/lentinan for advanced gastric cancer].
Hori T; Ikehara T; Takatsuka S; Fukuoka T; Tendo M; Tezuka K; Dan N; Nishino H; Hirakawa K
Gan To Kagaku Ryoho; 2011 Feb; 38(2):293-5. PubMed ID: 21368498
[TBL] [Abstract][Full Text] [Related]
7. [Pilot study of TS-1 combined with lentinan in patients with unresectable or recurrent advanced gastric cancer].
Nimura H; Mitsumori N; Tsukagoshi S; Nakajima M; Atomi Y; Suzuki S; Kusano M; Yoshiyuki T; Tokunaga A
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1289-96. PubMed ID: 14518408
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of TS-1 and lentinan combination immunochemotherapy in advanced or recurrent gastric cancer--pilot study aiming at a randomized trial].
Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Kikkawa N; Matsuura N
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1125-30. PubMed ID: 12938267
[TBL] [Abstract][Full Text] [Related]
9. [TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Matsuura N; Kikkawa N
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1791-3. PubMed ID: 14619521
[TBL] [Abstract][Full Text] [Related]
10. The effect of lentinan combination therapy for unresectable advanced gastric cancer.
Higashi D; Seki K; Ishibashi Y; Egawa Y; Koga M; Sasaki T; Hirano K; Mikami K; Futami K; Maekawa T; Sudo M
Anticancer Res; 2012 Jun; 32(6):2365-8. PubMed ID: 22641676
[TBL] [Abstract][Full Text] [Related]
11. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
Nakano H; Namatame K; Nemoto H; Motohashi H; Nishiyama K; Kumada K
Hepatogastroenterology; 1999; 46(28):2662-8. PubMed ID: 10522061
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
Taguchi T
Cancer Detect Prev Suppl; 1987; 1():333-49. PubMed ID: 3121179
[TBL] [Abstract][Full Text] [Related]
13. [The future of loco-regional treatment for advanced gastric cancer].
Nagahama T; Ando M; Ganno H; Ami K; Fukuda A; Maruyama M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2012-4. PubMed ID: 19106507
[TBL] [Abstract][Full Text] [Related]
14. A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for Advanced Stomach Cancer (TASC).
Morita S; Baba H; Tsuburaya A; Takiuchi H; Matsui T; Maehara Y; Sakamoto J
Jpn J Clin Oncol; 2007 Jun; 37(6):469-72. PubMed ID: 17584825
[TBL] [Abstract][Full Text] [Related]
15. [A case of advanced gastric cancer successfully treated by S-1 based chemotherapy].
Mitsuoka S; Onoda T; Tabuchi Y; Harafuji I
Gan To Kagaku Ryoho; 2008 Dec; 35(13):2401-4. PubMed ID: 19098411
[TBL] [Abstract][Full Text] [Related]
16. [A case report-the marked response to S-1 + CDDP chemotherapy for post-operative local recurrence of advanced gastric cancer].
Watanabe F; Iwasaki Y; Ohashi M; Nunobe S; Iwagami S; Takahashi K; Yamaguchi T; Matsumoto H; Yasutome M
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1970-2. PubMed ID: 18219868
[TBL] [Abstract][Full Text] [Related]
17. [Present state and prospects of adjuvant chemotherapy for gastric cancer].
Hori T; Ozawa R; Hanayama H; Yamashita H; Kaibe N; Matsumoto T; Oshima T; Takemura M; Kikuchi S; Sasako M
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1390-5. PubMed ID: 21918333
[TBL] [Abstract][Full Text] [Related]
18. [Administration of S-1 after gastrojejunostomy for unresectable gastric cancer with pyloric stenosis].
Nishikawa K; Iwase K; Fujii M; Matsuda C; Shimada K; Hirota M; Kimura T; Wada D; Nasu S; Tanaka Y
Gan To Kagaku Ryoho; 2009 Apr; 36(4):595-8. PubMed ID: 19381030
[TBL] [Abstract][Full Text] [Related]
19. [The efficacy of S-1 monotherapy as a 2nd/3rd-line therapy for unresectable recurrent colon cancer: Kanagawa conference of clinical oncology (KCCO)].
Yokoyama T; Tokuhara H; Egawa T; Hashimoto O; Seki H; Koyanagi K; Bessho T
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1667-70. PubMed ID: 19838025
[TBL] [Abstract][Full Text] [Related]
20. [Results of phase III study of lentinan].
Taguchi T; Furue H; Kimura T; Kondo T; Hattori T; Itoh I; Ogawa N
Gan To Kagaku Ryoho; 1985 Feb; 12(2):366-78. PubMed ID: 3918510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]